A previous study by Vojtek et al., has reported similar findings, assessing Claudin-4 expression in cell-block sections of 284 effusions, comprising 49 benign reactive lesions, 63 MPMs, and 172 metastatic tumors with multiple sources and cell differentiation. The gene discussed is CLDN4; the disease is metastatic neoplasm.